• SENSEX 80,599.91
    -585.67 (--0.72%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venus Remedies Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4791.0
  • ISIN : INE411B01019
530.00 -2 (-0.39%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    530.00

  • Today’s High

    542.70

  • Open

    535.90

  • Perv Close

    532.10

  • 52W Low

    270.25

  • 52W High

    567.80

Key Indicators

  • P/E(TTM)

    15.75

  • Mar.Cap (₹Cr.)

    708.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    441.01

  • Debt-Equity Ratio

    -0.39

  • AGM Date

    01-Aug-2025

  • EPS

    33.26

  • P/E Ratio

    15.75

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    708.45

  • RONW (%)

    6.01

  • ROCE (%)

    8.52

Score Board

  • Equity (₹ in Cr.)

    13.37

  • BV (₹)

    441.00

  • Sales( ₹ in Cr.)

    639.46

  • NP (in Cr.)

    44.46

  • NP Var(%)

    48.0

  • Div%

    0.0

  • CPS (₹)

    49.40

  • EPS (₹)

    33.30

  • Traded Value (₹ in Lakhs)

    700.43

  • 52 Week High

    567.80

  • 52 Week Low

    270.25

  • Price BSE

    524.0

  • Price NSE

    530.00

  • Market Capital( in Cr.)

    700.43

  • P/C Ratio

    10.60

  • P/E Ratio

    15.80

  • Price Vs.BV

    33.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 639.46 575.21 537.66 576.71 514.62 320.23
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 639.46 575.21 537.66 576.71 514.62 320.23
Other Income 30.69 11.32 10.17 8.43 50.37 34.93
Stock Adjustments -0.93 5.00 -14.26 -3.19 7.36 -6.21
Total Income 669.22 591.53 533.57 581.95 572.35 348.95
EXPENDITURE :            
Raw Materials 373.86 357.22 322.44 374.31 344.04 170.60
Power and Fuel Cost 4.91 4.99 4.17 3.78 3.39 3.41
Employee Cost 67.21 57.57 47.67 43.75 35.89 33.79
Other Manufacturing Expenses 12.34 10.07 6.18 6.47 4.51 3.63
Selling and Administration Expenses 109.58 89.17 81.16 76.40 87.29 59.53
Miscellaneous Expenses 0.64 0.31 0.26 0.00 9.17 40.16
Employee Benefit Expenses 67.21 57.57 47.67 43.75 35.89 33.79
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 568.54 519.33 461.88 504.71 484.28 311.12
Operating Profit 100.69 72.21 71.70 77.25 88.07 37.84
Interest 0.00 0.00 0.00 0.00 12.73 13.05
Gross Profit 100.69 72.21 71.70 77.25 75.34 24.79
Depreciation 21.62 25.55 31.37 32.58 34.28 31.05
Profit Before Tax 79.07 46.66 40.33 44.67 41.06 -6.26
Current Tax 21.86 12.22 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.65 3.93 11.36 -4.32 -13.21 1.96
Reported Net Profit 52.56 30.50 28.96 48.99 54.27 -8.23
Extraordinary Items 8.10 0.37 0.01 0.00 23.44 -6.85
Adjusted Net Profit 44.46 30.13 28.95 48.99 30.83 -1.38
Adjustment below Net Profit -0.48 -0.19 -0.46 0.24 -0.10 -0.47
P & L Balance brought forward 195.07 164.76 136.26 87.02 32.85 41.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 247.15 195.07 164.76 136.26 87.02 32.85
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 39.32 22.82 21.67 36.65 43.97 -6.67
Earnings Per Share(Adj)-Unit Curr 39.32 22.82 21.67 36.65 43.97 -6.67
Book Value 441.01 380.48 357.63 336.21 313.10 269.21
Book Value(Adj)-Unit Curr 441.01 380.48 357.63 336.21 313.10 269.21

Shareholding Pattern

  • Promoter Group

    41.76%

  • Public Share Holding

    58.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,300,000 17.21 2,300,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,281,997 24.55 3,281,997 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,581,997 41.76 5,581,997 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 299,882 2.24 299,882 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 14,295 0.11 14,295 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 314,177 2.35 314,177 7
2] Non Institution
Bodies Corporate 356,754 2.67 356,454 110
Clearing Members 1,100 0.01 1,100 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 248,014 1.86 248,014 354
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 321,246 2.40 321,246 501
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,970,252 14.74 1,970,252 33
Individuals holding nominal share capital up to Rs. 1 lakh 4,405,647 32.96 4,299,686 18,276
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 134,141 1.00 134,141 1
Sub Total 7,470,814 55.89 7,364,553 19,295
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,366,988 100.00 13,260,727 19,307

Company Background

Venus Remedies LtdPharmaceuticals - Indian - Formulations

  • Venus Remedies Ltd
  • BSE Code : 4791.0
  • ISIN : INE411B01019

  • Incorporation Year

    1989

  • Registered Office

    S C No 857 Cabin No 10 2nd Flr
    N A C Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

  • FAX

  • Chairman

    Pawan Chaudhary

  • Managing Director

    Pawan Chaudhary

  • Company Secretary

    Neha Kodan

  • Auditor

    J K Jain & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Venus Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venus Remedies 524.00 660.24 639.46 13.33 11.75
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10